Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 148,392 | 146,563 | 141,421 | 141,820 | 128,695 |
| Cost of Goods | 22,654 | 20,614 | 17,911 | 21,643 | 19,277 |
| Gross Profit | 125,738 | 125,949 | 123,510 | 120,177 | 109,418 |
| Operating Expenses | 60,125 | 60,265 | 61,054 | 57,977 | 58,786 |
| Operating Income | 66,267 | 66,298 | 63,367 | 62,843 | 50,909 |
| Other Income | 4,768 | 2,995 | 7,919 | 11,338 | 6,296 |
| Pre-tax Income | 71,035 | 69,293 | 71,286 | 74,181 | 57,205 |
| Income Tax | 18,252 | 17,185 | 14,549 | 18,245 | 13,321 |
| Net Income Continuous | 52,783 | 52,108 | 56,737 | 55,936 | 43,884 |
| Net Income | $52,783 | $52,108 | $56,737 | $55,936 | $43,884 |
| EPS Basic Total Ops | 0.43 | 0.43 | 0.47 | 0.46 | 0.37 |
| EPS Basic Continuous Ops | 0.43 | 0.43 | 0.47 | 0.47 | 0.37 |
| EPS Diluted Total Ops | 0.42 | 0.41 | 0.45 | 0.44 | 0.35 |
| EPS Diluted Continuous Ops | 0.42 | 0.41 | 0.45 | 0.45 | 0.35 |
| EPS Diluted Before Non-Recurring Items | 0.64 | 0.62 | 0.63 | 0.66 | 0.53 |
| EBITDA(a) | $75,683 | $75,758 | $72,827 | $72,301 | $60,360 |